Zobrazeno 1 - 6
of 6
pro vyhledávání: '"L. I. Kozlovskaya"'
Autor:
E. V. Shipaeva, O. V. Filon, A. V. Zintchenko, G. A. Shipunov, A. A. Dmitrieva, M. S. Lemak, S. A. Grishin, E. I. Trofimets, K. L. Kryshen, L. I. Kozlovskaya, A. S. Lunin, V. D. Apolokhov, S. F. Barbashov, Ya. V. Lavrovsky, M. Yu. Samsonov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 22, Iss 4, Pp 414-434 (2022)
Finding effective and safe medicines to fight SARS-CoV-2 infection is an urgent task. RPH-137 is an original trap fusion protein against SARS-CoV-2 virus. It comprises the angiotensin-converting enzyme type 2 extracellular domain and the human IgG1 F
Externí odkaz:
https://doaj.org/article/b6498fb9f9704919973eae259a4a5c4e
Autor:
G. M. Ignatyev, I. A. Leneva, A. V. Atrasheuskaya, L. I. Kozlovskaya, N. P. Kartashova, I. T. Fediakina, E. Yu. Shustova, A. A. Sinyugina, V. V. Zverev, V. P. Trukhin, A. A. Ishmukhametov
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 98, Iss 6, Pp 648-656 (2022)
Introduction. In clinical practice, the differential diagnosis of COVID-19 can be challenging during the flu season, entailing serious consequences such as delays in appropriate control measures against the SARS-CoV-2 pandemic. Another problem is pos
Externí odkaz:
https://doaj.org/article/d3ee093871364c6b8e22b1c9e34e26f7
Autor:
A. Yu. Popova, E. B. Ezhlova, A. A. Melnikova, N. S. Morozova, Yu. M. Mikhailova, O. E. Ivanova, L. I. Kozlovskaya, T. P. Eremeeva, A. P. Gmyl, E. A. Korotkova, O. Yu. Baykova, A. Yu. Krasota, А. V. Ivanenko, M. S. Yarmolskaya, I. V. Kovalchuk, E. N. Romanenko
Publikováno v:
Инфекция и иммунитет, Vol 10, Iss 1, Pp 90-98 (2020)
Since April 2016 after global cessation of using trivalent oral poliovirus vaccine (tOPV) and switch to bivalent OPV consisting of polioviruses types 1 and 3 (the “switch”), any isolation of type 2 poliovirus has been regarded as an event of extr
Externí odkaz:
https://doaj.org/article/8787be3f9cf6414b9faecebe3649d002
Publikováno v:
Инфекция и иммунитет, Vol 8, Iss 4 (2018)
Externí odkaz:
https://doaj.org/article/386f81458450497a805b3238ad155847
Autor:
M. V. Sidorova, R. S. Bibilashvili, D. V. Avdeev, U. S. Kozhokar, M. E. Palkeeva, M. V. Ovchinnikov, A. S. Molokoedov, D. A. Shirokov, A. V. Semyonova, V. I. Uvarova, P. O. Kulyaev, E. V. Khvatov, A. A. Ignatova, A. V. Feofanov, D. I. Osolodkin, Yu. B. Porozov, L. I. Kozlovskaya, A. A. Ishmukhametov, Ye. V. Parfyonova, A. M. Egorov
Publikováno v:
Doklady. Biochemistry and biophysics.
Abstract The aim of this work was to design and characterize peptides based on the α-helices h1 and h2 of the ACE2 receptor, forming the interaction interface between the receptor-binding domain (RBD) of the SARS-CoV-2 S protein and the cellular ACE
Autor:
A A, Maslova, E C, Matyugina, E Yu, Shustova, V P, Volok, L I, Kozlovskaya, S N, Kochetkov, A L, Khandazhinskaya
Publikováno v:
Molekuliarnaia biologiia. 56(3)
The development of specific drugs against SARS-CoV-2 infection is a major challenge facing global science and healthcare. Despite numerous attempts, there are still no truly effective drugs. Currently, the main approach in the creation of drugs again